Corporate Board Profile
Tech Score: 8/100
1 mention(s) identify SUSAN E. SIEGEL as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| ALIGN TECHNOLOGY INC | 2023-04-05 | Susan E. Siegel, 62, served as GE’s Chief Innovation Officer (2017-2019) and CEO of GE Ventures & Licensing (2012-2017). Before GE, she was a General Partner at Mohr Davidow Ventures, leading investments in personalized medicine, life sciences & digital health. During the early days of the human genome project, Ms. Siegel led Affymetrix as a director and President, one of the fastest growing genomics companies. Ms. Siegel earned a M.S. in Biochemistry and Molecular Biology from Boston University Medical School and a B.S. in Biology from the University of Puerto Rico. | Ms. Siegel has a M.S. in Biochemistry and Molecular Biology and has led technology and innovation roles at GE Ventures and Affymetrix, a genomics company, indicating strong technical and software-related skills. |
| Filing Date | Source Excerpt |
|---|---|
| 2017-04-06 | Ms. Siegel holds a B.S. in Biology from the University of Puerto Rico and a M.S. in Biochemistry and Molecular Biology from Boston University Medical School. She has experience growing biotechnology companies and leading innovation in personalized medicine. |
| 2018-04-05 | Ms. Siegel holds a B.S. in Biology from the University of Puerto Rico and a M.S. in Biochemistry and Molecular Biology from Boston University Medical School. She has been CEO of GE Ventures and Chief Innovation Officer at General Electric. |
| 2019-04-04 | Ms. Siegel holds a B.S. in Biology from the University of Puerto Rico and a M.S. in Biochemistry and Molecular Biology from Boston University Medical School. She has been Chief Executive Officer of GE Ventures and Chief Innovation Officer at GE. |
| 2020-04-06 | Ms. Siegel has been a member of our Board since 2017. In November 2017, she was appointed as Chief Innovation Officer at General Electric and Chief Executive Officer of GE Business Innovations, GE’s growth and innovation business. She was CEO of GE Ventures since 2012, which was subsumed into her new role. Prior to joining GE, from May 2006 to May 2012, she was a General Partner at Mohr Davidow Ventures, where she led healthcare and life science investments. From April 1998 to April 2006, Ms. Siegel was at Affymetrix, Inc. where she served as President and as a member of the board of directors. Since Feb 2019, Ms. Siegel has served on the board of directors of Illumina, Inc., a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. She also serves on the board of directors of The Engine at MIT and at The Kaiser Family Foundation. Ms. Siegel holds a B.S. in Biology from the University of Puerto Rico and a M.S. in Biochemistry and Molecular Biology from Boston University Medical School. |
| 2021-04-07 | Susan E. Siegel Former Chief Innovation Officer of General Electric Company Skills and Qualifications: Extensive experience identifying, funding, pioneering and implementing industry-shifting ideas in life sciences and healthcare CEO with extensive business strategy, market building, finance, M&A experience. |
| 2022-04-05 | Susan E. Siegel, 61, served as GE’s Chief Innovation Officer and CEO of GE Ventures & Licensing... Ms. Siegel earned a M.S. in Biochemistry and Molecular Biology from Boston University Medical School and a B.S. in Biology from the University of Puerto Rico. |
| 2023-04-05 | Susan E. Siegel, 62, served as GE’s Chief Innovation Officer (2017-2019) and CEO of GE Ventures & Licensing (2012-2017). Before GE, she was a General Partner at Mohr Davidow Ventures, leading investments in personalized medicine, life sciences & digital health. During the early days of the human genome project, Ms. Siegel led Affymetrix as a director and President, one of the fastest growing genomics companies. Ms. Siegel earned a M.S. in Biochemistry and Molecular Biology from Boston University Medical School and a B.S. in Biology from the University of Puerto Rico. |
| 2024-04-09 | Education: B.S. in Biology from University of Puerto Rico; M.S. in Biochemistry and Molecular Biology from Boston University Medical School |
| 2025-04-08 | B.S. in Biology from University of Puerto Rico; M.S. in Biochemistry and Molecular Biology from Boston University Medical School; Chief Innovation Officer, GE; CEO, GE Ventures and Licensing. |
| Filing Date | Source Excerpt |
|---|---|
| 2019-04-16 | Ms. Siegel holds a B.S. in Biology from the University of Puerto Rico and a M.S. in Biochemistry and Molecular Biology from Boston University Medical School. She was CEO of GE Ventures and General Partner at Mohr Davidow Ventures. |
| 2021-04-16 | Former Chief Innovation Officer of General Electric; CEO of GE Business Innovations; President of Affymetrix, Inc.; B.S. in Biology from University of Puerto Rico; M.S. in Biochemistry and Molecular Biology from Boston University Medical School. |
| 2022-04-14 | B.S. in Biology from University of Puerto Rico; M.S. in Biochemistry and Molecular Biology from Boston University Medical School; former Chief Innovation Officer of General Electric. |
| 2024-04-04 | Ms. Siegel’s extensive experience leading and growing life science companies and driving innovation, as well as her knowledge of genomics markets and technology, greatly enhances the Board’s understanding of our customers, technology roadmap, and the needs of our business. |
Data sourced from SEC filings. Last updated: 2026-02-03